1 – 5 of 9
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
A randomized phase II/III study of naptumomab estafenatox + IFNα versus IFNα in renal cell carcinoma : Final analysis with baseline biomarker subgroup and trend analysis
(
- Contribution to journal › Article
- 2014
-
Mark
Assessment of the bone scan index in a randomized placebo-controlled trial of tasquinimod in men with metastatic castration-resistant prostate cancer (mCRPC).
(
- Contribution to journal › Article
- 2013
-
Mark
The Tumor Targeted Superantigen ABR-217620 Selectively Engages TRBV7-9 and Exploits TCR-pMHC Affinity Mimicry in Mediating T Cell Cytotoxicity.
(
- Contribution to journal › Article
- 2008
-
Mark
Systemic IGF-I administration stimulates the in vivo growth of early, but not advanced, renal cell carcinoma.
(
- Contribution to journal › Article
- 2007
-
Mark
Cutting edge : Evidence of direct TCR α-chain interaction with superantigen
(
- Contribution to journal › Article